[Focal therapies: An alternative option for low-risk prostate cancer management?]

Presse Med. 2017 Oct;46(10):935-939. doi: 10.1016/j.lpm.2017.09.012. Epub 2017 Oct 12.
[Article in French]

Abstract

Recommended options for low-risk prostate cancer treatment are active surveillance, radical treatments or watchful waiting. Focal therapies are currently assessed for low risk prostate cancer treatment. Focal therapies can be performed in research protocols. Oncologic results of these focal treatments are encouraging and show excellent tolerance with few complications. Radical treatments are still possible after focal therapies failure. Focal therapies are a possible solution to over-treatment issue of low risk prostate cancers.

MeSH terms

  • Humans
  • Male
  • Prostatic Neoplasms / therapy*
  • Risk Assessment